Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Chemomab Therapeutics Ltd DRC

CMMB
Current price
1.27 USD -0.07 USD (-5.22%)
Last closed 1.42 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 15 925 280 USD
Yield for 12 month -1.55 %
1Y
3Y
5Y
10Y
15Y
CMMB
21.11.2021 - 28.11.2021

Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, discovers and develops therapeutics for the treatment of fibrotic and inflammatory diseases in the United States. Its lead product candidate is CM-101, a humanized monoclonal antibody attenuates the basic function of CCL24 that is in phase 2 clinical trial for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). Chemomab Therapeutics Ltd. was founded in 2011 and is based in Tel Aviv, Israel. Address: Building 7, Tel Aviv, Israel, 6158002

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5.67 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-66 827 USD

Last Year

-57 773 USD

Current Quarter

Last Quarter

-16 173 USD

Key Figures CMMB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -20 390 250 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -48.23 %
PEG Ratio
Return On Equity TTM -93.67 %
Wall Street Target Price 5.67 USD
Revenue TTM
Book Value 0.94 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.54 USD
Diluted Eps TTM -1.54 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CMMB

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CMMB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:16
Payout Ratio
Last Split Date 17.03.2021
Dividend Date

Stock Valuation CMMB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 13.0039
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.3331
Price Book MRQ 1.1946

Financials CMMB

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CMMB

For 52 weeks

0.42 USD 1.38 USD
50 Day MA 0.99 USD
Shares Short Prior Month 99 698
200 Day MA 0.75 USD
Short Ratio 0.84
Shares Short 100 465
Short Percent 0.71 %

Dynamics of changes in the value of assets

S

SIX

0.045 AUD Sprintex Limited +0 (+12.5%)
Detailed analytics
3

31M

0.027 EUR MOBILITYONE 0 (0%)
Detailed analytics
T

TLIS

8.66 USD Talis Biomedical Corp +0.14 (+1.64%)
Detailed analytics
T

TMRC

0.23 USD Texas Rare Earth Resources Corp 0 (0%)
Detailed analytics
I

IHP

373.50 GBX IntegraFin Holdings plc +0.08 (+1.77%)
Detailed analytics